文献速递技术与安全PETMR

淋巴瘤患者的18F-FDG-PET/MRI

18F-FDG-PET/MRI in lymphoma patients.
PubMed 文献 · Eur J Radiol · 2017-01-23

本文介绍混合PET/MRI技术用于淋巴瘤的临床应用:整合系统可去除CT以降低辐射剂量,利用MRI软组织与骨髓高对比度结合PET记录,图像质量与PET/CT相当。霍奇金淋巴瘤中期评估采用Deauville评分;弥漫大B细胞淋巴瘤的PET预后价值需结合亚型评估;PET/MRI可用于滤泡性淋巴瘤治疗后复发评估及转化确认;伯基特淋巴瘤诱导治疗后阴性结果对复发预后有高阴性预测值。

要点

  • PET/MRI利用MRI软组织与骨髓高对比度结合PET,图像质量与PET/CT相当。
  • 霍奇金淋巴瘤中期疗效评估使用Deauville评分系统。
  • 弥漫大B细胞淋巴瘤的PET预后价值需结合亚型评估。

核心结论

  • 混合PET/MRI整合系统可去除CT贡献以降低混合成像辐射剂量,且PET图像质量与PET/CT相当;不同淋巴瘤亚型的PET应用价值与评估方式不同。

研究设计与样本

  • 本文为综述性文章,未报告系统检索范围、纳入文献数量或样本量;涉及整合型PET/MRI混合成像系统及PET/CT对比研究。

关键影像表现/征象

  • 霍奇金淋巴瘤为放射性药物高摄取组织,治疗有效后摄取按比例下降。
  • 弥漫大B细胞淋巴瘤的PET预后价值与亚型评估相关。
  • 滤泡性淋巴瘤已治疗后,PET/MRI扫描可用于评估复发或确认转化为更具侵袭性的形式。
  • 儿童与成人伯基特淋巴瘤诱导治疗后阴性结果对复发预后有高阴性预测值。

诊断标准与关键数值

  • 霍奇金淋巴瘤中期检查采用Deauville评分系统评估治疗效果。

临床应用与阅片要点

  • 霍奇金淋巴瘤中期疗效评估采用Deauville评分。
  • 弥漫大B细胞淋巴瘤解读PET预后时需结合亚型评估。
  • 滤泡性淋巴瘤治疗后可用PET/MRI评估复发或确认组织学转化。
  • 伯基特淋巴瘤诱导治疗后阴性结果提示复发预后阴性预测值高。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The introduction of hybrid PET/MRI imaging using integrated systems into clinical practice has opened up the possibility of reducing the radiation dose from hybrid imaging by eliminating the contribution from computed tomography. Studies comparing the possibilities of PET/CT and PET/MRI imaging demonstrated it is possible to use the advantages of the high contrast resolution of magnetic resonance for soft tissue and bone marrow along with PET records in a quality comparable to PET/CT imaging. The significant feature for PET imaging in Hodgkińs lymphoma is that it is a tissue with high levels of radiopharmaceutical accumulation, which decreases proportionally after successful therapeutic effect, the effect of therapy is assessed using Deauville score system on interim examinations. While the efficacy of prognosis determined using the Deauville scale in HL is widely accepted, it turns out that in DLBCL, the prognostic value of PET imaging is bound to the evaluation of subtypes. PET/MRI scanning can be used to evaluate a relapse if follicular lymphoma has already been treated, or to confirm transformation into more aggressive forms. In children and adults with Burkitt's lymphoma, negative findings after induction therapy have a high negative predictive value for relapse prognosis.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Ferdová E, Ferda J, Baxa J, et al. 18F-FDG-PET/MRI in lymphoma patients. Eur J Radiol. 2017. PMID: 28132716. doi:10.1016/j.ejrad.2017.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。